Andrew McQuillin

Dr. Andrew McQuillin

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
RSRebecca Sims
Rebecca Sims
JBJoshua C. Bis
Joshua C. Bis
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance

6 September 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DHDenise Harold
Denise Harold
RARichard Abraham
Richard Abraham
PHPaul Hollingworth
Paul Hollingworth
RSRebecca Sims
Rebecca Sims
AGAmy Gerrish
Amy Gerrish
JWJulie Williams
Julie Williams
Julie Williams and colleagues report a genome-wide association study for Alzheimer's disease. They identify variants at the CLU and PICALM loci associated with susceptibility to late-onset Alzheimer's disease. We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 cases and 7,848 controls), we replicated the established association with the apolipoprotein E (APOE) locus (most significant SNP, rs2075650, P = 1.8 × 10−157) and observed genome-wide significant association with SNPs at two loci not previously associated with the disease: at the CLU (also known as APOJ) gene (rs11136000, P = 1.4 × 10−9) and 5′ to the PICALM gene (rs3851179, P = 1.9 × 10−8). These associations were replicated in stage 2 (2,023 cases and 2,340 controls), producing compelling evidence for association with Alzheimer's disease in the combined dataset (rs11136000, P = 8.5 × 10−10, odds ratio = 0.86; rs3851179, P = 1.3 × 10−9, odds ratio = 0.86).

3 April 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
PHPaul Hollingworth
Paul Hollingworth
DHDenise Harold
Denise Harold
RSRebecca Sims
Rebecca Sims
AGAmy Gerrish
Amy Gerrish
JLJean-Charles Lambert
Jean-Charles Lambert
JWJulie Williams
Julie Williams
Julie Williams, Michael Owen and colleagues report staged follow-up and meta-analyses of genome-wide association studies for Alzheimer's disease from the GERAD+ consortium. They identify common variants at ABCA7 and MS4A6A/MS4A4E associated with Alzheimer's disease and support for several additional susceptibility loci. We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10−5. We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10−17; including ADGC data, meta P = 5.0 × 10−21) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10−14; including ADGC data, meta P = 1.2 × 10−16) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10−4; including ADGC data, meta P = 8.6 × 10−9), CD33 (GERAD+, P = 2.2 × 10−4; including ADGC data, meta P = 1.6 × 10−9) and EPHA1 (GERAD+, P = 3.4 × 10−4; including ADGC data, meta P = 6.0 × 10−10).

1 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ECeQTLGen Consortium
eQTLGen Consortium
ESEli A. Stahl
Eli A. Stahl
BCBIOS Consortium
BIOS Consortium
TCthe Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
GBGerome Breen
Gerome Breen
PSPamela Sklar
Pamela Sklar
Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P < 1 × 10−4 in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P < 5 × 10−8) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder.

1 October 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
BVBjarni J. Vilhjálmsson
Bjarni J. Vilhjálmsson
JYJian Yang
Jian Yang
HFHilary K. Finucane
Hilary K. Finucane
AGAlexander Gusev
Alexander Gusev
SLSara Lindström
Sara Lindström
WZWei Zheng
Wei Zheng

18 September 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PGPsychiatric GWAS Consortium Bipolar Disorder Working Group
Psychiatric GWAS Consortium Bipolar Disorder Working Group
PSPamela Sklar
Pamela Sklar
SRStephan Ripke
Stephan Ripke
LSLaura J Scott
Laura J Scott
OAOle A Andreassen
Ole A Andreassen
SPShaun M Purcell
Shaun M Purcell